AGAP2 and non-small cell lung carcinoma: Consistent with the results of our study, accumulating studies have continued to suggest that AGAP2-AS1 is highly expressed in non-small-cell lung cancer and closely correlated with tumor size and advanced pathological stage of non-small-cell lung cancer.8